w10.0.26 | c9.0.88.82
PROD | u7.5.14
Header Image service-corner
 

 

print content
increase font
decrease font

NGS 2.0 experience: Eurofins Genomics invests in new technology and redefines industry standards

 
17/04/2019 Ebersberg, Germany
 
Investing in customer service: Eurofins Genomics, international provider of genomics services, now offers next generation sequencing (NGS) services on the NovaSeq6000 (Illumina Inc., US). Using Illumina’s latest and most efficient high throughput sequencing platform, Eurofins Genomics sets new benchmarks in both quality and turnaround time. With the addition of the NovaSeq 6000, Eurofins Genomics now offers tailor-made services on a comprehensive set of NGS platforms including the HighSeq 4000, HiSeq 2500, MiSeq, and equal technology from PacBio.
 

NGS 2.0 experience: Eurofins Genomics invests in new technology and redefines industry standards

 

Ebersberg, Germany, 17th April 2019

Investing in customer service: Eurofins Genomics, international provider of genomics services, now offers next generation sequencing (NGS) services on the NovaSeq6000 (Illumina Inc., US). Using Illumina’s latest and most efficient high throughput sequencing platform, Eurofins Genomics sets new benchmarks in both quality and turnaround time. With the addition of the NovaSeq 6000, Eurofins Genomics now offers tailor-made services on a comprehensive set of NGS platforms including the HighSeq 4000, HiSeq 2500, MiSeq, and equal technology from PacBio.

Eurofins Genomics continues to invest in new technology to increase sequencing capacity and to further expand its express suite. With a shortened delivery time for analyses like whole genome sequencing (WGS), whole exome sequencing (WES), and molecular tumor-profiling,  Eurofins Genomics saves customers valuable time and enables them to plan with less lead time. The seamless and lean integration of the new NGS platform enables innovative new services possible, such as the 8-day exome. Since implementation at the end of 2018, multiple customer projects have been completed successfully and the Novaseq6000 is meanwhile a full member of Eurofins Genomics’ NGS machine park.

 “With the NovaSeq 6000 we invest in speed and quality to offer our customers the best services in the shortest time.” Dr. Michael Hadem (CEO Genomics Services Europe).

 
 
Scroll to top ^^